A Covid-19 antibody treatment developed by GlaxoSmithKline PLC and Vir Biotechnology Inc. was effective against the Omicron variant in early laboratory studies, the companies said, setting it apart from similar therapies that appear to work less well against the highly mutated strain.
The companies said Thursday that they had tested the drug, called sotrovimab, against certain individual mutations found in Omicron, which has now been detected in at least 24 countries,Glaxo and Vir said the findings were preliminary and they would need to test the treatment against the whole of the mutated spike protein found in the variant to confirm the result. The companies published a preliminary research paper on the findings, which haven’t yet been peer reviewed.
My son James Bonds 215403, 20 yrs in prison, and the Judge and DA said he had no involvement. Make it make sense... Help him plz.
Supported by the Bill & Melinda Gates Foundation. Billy has his fingers in the pie everywere.
US Gov. NIH website 2011: 'IVERMECTIN ... immeasurable beneficial impact in improving the lives of BILLIONS of PEOPLE - being used FREE of charge ... 'wonder drug'' Can we have NEW *EUA* drugs - to ultimately market ... if there's an existing treatment?
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: Forbes - 🏆 394. / 53 Read more »
Source: PreventionMag - 🏆 141. / 63 Read more »